Healthtech Investors & VC Firms in Japan

184 firms in this list, with a median first check of $500K. 43 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SB SBVA JLECSLBJ12 people · Follows rounds	88🔒	Seoul	KR	Seed–Growth	$1M – $2.5M	+ Add to CRM
MI Mitsui Global Investment KNPSTTYK12 people	88🔒	Menlo Park	US	Pre-Seed–Late Stage	$500K – $10M	+ Add to CRM
MA Magna Investment 박송이전17 people	88🔒	Seoul	KR	Seed–Growth	—	+ Add to CRM
HE HearstLab LBEBBDER6 people · Leads rounds	88🔒	New York	US	Pre-Seed–Seed	$500K – $1M	+ Add to CRM
IN Industrial Technology Investment Corporation ACACBTBH15 people	88🔒	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
AS Asia Africa Investment & Consulting (AAIC) STHTHINI16 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
LY LYFE Capital AWFCHLJZ22 people · Follows rounds	88🔒	Menlo Park	US	Seed–Late Stage	—	+ Add to CRM
MB MBK Partners MBBBDIHY29 people · Leads rounds	88🔒	Seoul	KR	Growth–Late Stage	—	+ Add to CRM
PR Primer Sazze Partners KKKLSKU(9 people · Follows rounds	88🔒	Seoul	KR	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
QU Quantonation CJOTWZJM15 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Growth	—	+ Add to CRM
VE Vertex Venture Management Pte. Ltd. KLARCSJL23 people	88🔒	Singapore	SG	Seed–Growth	—	+ Add to CRM
SP Spiral Ventures CRIGSKYH8 people · Leads rounds	88🔒	Jakarta	ID	Seed–Series A	$1M	+ Add to CRM
AS Astellas Venture Management LLC HKHUSKSM10 people	88🔒	South San Francisco	US	Seed–Series C	$200K – $5M	+ Add to CRM
MO Mosaic Venture Lab JYVHBBCW15 people	88🔒	Taipei City	TW	Seed	—	+ Add to CRM
EA Eaton Square BADBMUAM25 people	88🔒	London	GB	Series A–Growth	—	+ Add to CRM
CA Carbide Ventures KHBTDWHY9 people	88🔒	Palo Alto	US	Pre-Seed–Series A	—	+ Add to CRM
ME MedTech Actuator	88🔒	—	AU	Seed–Series B	—	+ Add to CRM
DA Darwin Venture Management SFYWEWKK19 people	88🔒	Taipei	TW	Seed–Late Stage	$1M – $5M	+ Add to CRM
NE Newton Biocapital APGTAWPD16 people · Leads rounds	88🔒	Brussels	BE	Seed–Series A	—	+ Add to CRM
VE Vertex Growth JLHCKLLP16 people	88🔒	Singapore	SG	Growth	—	+ Add to CRM
3B 3B Future Health Fund FGASFGMB11 people	88🔒	Monaco	MC	Pre-Seed–Series A	$12M	+ Add to CRM
RE Reinventure Group DGSCJBLT5 people · Follows rounds	88🔒	Sydney	AU	Seed–Series A	—	+ Add to CRM
EI Eisai Innovation, Inc. YMR(PWKQ4 people	88🔒	Cambridge	US	Seed–Series A	$5M	+ Add to CRM
SE Seveno Capital JRASACAS11 people	88🔒	Singapore	SG	Pre-Seed–Growth	—	+ Add to CRM

SBVA

SeoulSeed–Growth$1M – $2.5M

JLECSLBJ12 people

Mitsui Global Investment

Menlo ParkPre-Seed–Late Stage$500K – $10M

KNPSTTYK12 people

Magna Investment

SeoulSeed–Growth

박송이전17 people

HearstLab

New YorkPre-Seed–Seed$500K – $1M

LBEBBDER6 people

Industrial Technology Investment Corporation

TaipeiSeed–Late Stage

ACACBTBH15 people

Asia Africa Investment & Consulting (AAIC)

SingaporeSeed–Late Stage

STHTHINI16 people

LYFE Capital

Menlo ParkSeed–Late Stage

AWFCHLJZ22 people

MBK Partners

SeoulGrowth–Late Stage

MBBBDIHY29 people

Primer Sazze Partners

SeoulPre-Seed–Series A$500K – $3M

KKKLSKU(9 people

Quantonation

ParisPre-Seed–Growth

CJOTWZJM15 people

Vertex Venture Management Pte. Ltd.

SingaporeSeed–Growth

KLARCSJL23 people

Spiral Ventures

JakartaSeed–Series A$1M

CRIGSKYH8 people

Astellas Venture Management LLC

South San FranciscoSeed–Series C$200K – $5M

HKHUSKSM10 people

Mosaic Venture Lab

Taipei CitySeed

JYVHBBCW15 people

Eaton Square

LondonSeries A–Growth

BADBMUAM25 people

Carbide Ventures

Palo AltoPre-Seed–Series A

KHBTDWHY9 people

MedTech Actuator

Seed–Series B

Darwin Venture Management

TaipeiSeed–Late Stage$1M – $5M

SFYWEWKK19 people

Newton Biocapital

BrusselsSeed–Series A

APGTAWPD16 people

Vertex Growth

SingaporeGrowth

JLHCKLLP16 people

3B Future Health Fund

MonacoPre-Seed–Series A$12M

FGASFGMB11 people

Reinventure Group

SydneySeed–Series A

DGSCJBLT5 people

Eisai Innovation, Inc.

CambridgeSeed–Series A$5M

YMR(PWKQ4 people

Seveno Capital

SingaporePre-Seed–Growth

JRASACAS11 people

Data sourced from public filings and firms' own websites — see our methodology.